文献速递免疫规划

非人灵长类动物静脉接种卡介苗相比皮内途径诱导更高滴度、更高亲和力及更强调理能力的血清抗体

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.
PubMed 文献 · Vaccine · 2024-11-10

研究在非人灵长类动物中比较静脉、皮内及气溶胶三种途径接种卡介苗后的血清抗体应答。静脉接种卡介苗后血清中结核分枝杆菌特异性IgG、IgA和IgM滴度优于皮内或气溶胶途径,IgG调理分枝杆菌表面能力增强,且首次报告静脉接种卡介苗动物结核分枝杆菌特异性IgG亲和力高于皮内或气溶胶接种动物。IgG亲和力与气溶胶结核分枝杆菌攻击保护指标显著相关。

要点

  • 静脉接种卡介苗后血清结核分枝杆菌特异性IgG、IgA和IgM滴度优于皮内或气溶胶途径。
  • 静脉接种卡介苗诱导的IgG调理分枝杆菌表面能力增强,且亲和力高于皮内或气溶胶接种。
  • IgG亲和力与气溶胶结核分枝杆菌攻击保护指标显著相关。

核心结论

  • 静脉接种卡介苗在非人灵长类动物中诱导的血清抗体在滴度、亲和力和调理能力方面优于皮内或气溶胶途径,抗体可能作为静脉接种卡介苗 superior 保护作用的标志和/或介质,开发与评估结核疫苗时应考虑抗体质量与数量。

研究设计与样本

  • 研究在非人灵长类动物中比较静脉、皮内及气溶胶途径接种卡介苗后的血清抗体应答。

主要发现

  • 静脉接种卡介苗后血清结核分枝杆菌特异性IgG、IgA和IgM滴度优于皮内或气溶胶途径。
  • 静脉接种卡介苗诱导的IgG调理分枝杆菌表面能力增强。
  • 首次报告静脉接种卡介苗动物结核分枝杆菌特异性IgG亲和力高于皮内或气溶胶接种动物。
  • IgG亲和力与气溶胶结核分枝杆菌攻击保护指标显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A new and more effective tuberculosis (TB) vaccine is urgently needed, but development is hampered by the lack of validated immune correlates of protection. Bacillus Calmette Guérin (BCG) vaccination by the aerosol (AE) and intravenous (IV) routes has been shown to confer superior levels of protection from challenge with Mycobacterium tuberculosis (M.tb) in non-human primates (NHP) compared with standard intradermal (ID) administration. This finding offers a valuable opportunity to investigate which aspects of immunity are associated with improved control of M.tb and may represent biomarkers or correlates of protection. As TB vaccine research to date has focused largely on cellular immunity, we aimed to better characterize the poorly-understood serum antibody response to BCG administered by different routes of vaccination in NHP. We demonstrate superior M.tb-specific IgG, IgA, and IgM titers in serum following IV BCG vaccination compared to the ID or AE routes. We also observe improved capacity of IgG induced by IV BCG to opsonize the surface of mycobacteria, and report for the first time that M.tb-specific IgG from IV BCG vaccinated animals is of higher avidity compared with IgG from ID or AE BCG vaccinated animals. Notably, we identified a significant correlation between IgG avidity and measures of protection from aerosol M.tb challenge. Our findings highlight a potential role for antibodies as markers and/or mediators of the superior vaccine-induced protection IV BCG confers against TB and suggest that quality, as well as quantity, of antibodies should be considered when developing and evaluating TB vaccine candidates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Peralta Alvarez MP, Downward K, White A, et al. Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route. Vaccine. 2024. PMID: 39522337. doi:10.1016/j.vaccine.2024.126444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。